Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bioadaptives (BDPT) Other Non-Current Assets (2023 - 2025)

Bioadaptives' Other Non-Current Assets history spans 3 years, with the latest figure at $2500.0 for Q4 2025.

  • On a quarterly basis, Other Non-Current Assets changed 0.0% to $2500.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $2500.0, a 0.0% change, with the full-year FY2025 number at $2500.0, changed 0.0% from a year prior.
  • Other Non-Current Assets hit $2500.0 in Q4 2025 for Bioadaptives, roughly flat from $2500.0 in the prior quarter.
  • Over the last five years, Other Non-Current Assets for BDPT hit a ceiling of $2500.0 in Q4 2023 and a floor of $2500.0 in Q4 2023.
  • Historically, Other Non-Current Assets has averaged $2500.0 across 3 years, with a median of $2500.0 in 2023.
  • The widest YoY moves for Other Non-Current Assets: up 0.0% in 2024, down 0.0% in 2024.
  • Tracing BDPT's Other Non-Current Assets over 3 years: stood at $2500.0 in 2023, then changed by 0.0% to $2500.0 in 2024, then changed by 0.0% to $2500.0 in 2025.
  • Business Quant data shows Other Non-Current Assets for BDPT at $2500.0 in Q4 2025, $2500.0 in Q3 2025, and $2500.0 in Q2 2025.